Search Results - "Lawrence H. Boise"
-
1
How I treat high-risk myeloma
Published in Blood (24-09-2015)“…The treatment of patients with myeloma has dramatically changed over the past decade due in part to the development of new agents and myeloma-specific targets…”
Get full text
Journal Article -
2
Cell of Origin and Genetic Alterations in the Pathogenesis of Multiple Myeloma
Published in Frontiers in immunology (21-05-2019)“…B cell activation and differentiation yields plasma cells with high affinity antibodies to a given antigen in a time-frame that allows for host protection…”
Get full text
Journal Article -
3
Stromal Support of Metabolic Function through Mitochondrial Transfer in Multiple Myeloma
Published in Cancer research (Chicago, Ill.) (01-05-2019)“…Marlein and colleagues demonstrate in multiple myeloma, bone marrow stromal cells transfer mitochondria to myeloma cells to increase cellular respiration,…”
Get full text
Journal Article -
4
Multiple myeloma immunoglobulin lambda translocations portend poor prognosis
Published in Nature communications (23-04-2019)“…Multiple myeloma is a malignancy of antibody-secreting plasma cells. Most patients benefit from current therapies, however, 20% of patients relapse or die…”
Get full text
Journal Article -
5
Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma
Published in Nature communications (06-03-2020)“…The BCL-2 antagonist venetoclax is highly effective in multiple myeloma (MM) patients exhibiting the 11;14 translocation, the mechanistic basis of which is…”
Get full text
Journal Article -
6
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
Published in Cancer cell (13-08-2018)“…Platinum-based chemotherapeutics represent a mainstay of cancer therapy, but resistance limits their curative potential. Through a kinome RNAi screen, we…”
Get full text
Journal Article -
7
BCL2 dependency in diffuse large B-cell lymphoma: it's a family affair
Published in Haematologica (Roma) (01-08-2020)Get full text
Journal Article -
8
Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells
Published in Blood (15-06-2006)“…Multiple myeloma (MM) is an incurable plasma cell malignancy. The 26S proteasome inhibitor, bortezomib, selectively induces apoptosis in MM cells; however, the…”
Get full text
Journal Article -
9
MAX is an epigenetic sensor of 5-carboxylcytosine and is altered in multiple myeloma
Published in Nucleic acids research (17-03-2017)“…The oncogenic transcription factor MYC and its binding partner MAX regulate gene expression by binding to DNA at enhancer-box (E-box) elements 5΄-CACGTG-3΄. In…”
Get full text
Journal Article -
10
The Tao of myeloma
Published in Blood (18-09-2014)“…Multiple myeloma is a plasma cell malignancy in which significant advances have been observed during the last 15 years. Our understanding of the disease has…”
Get full text
Journal Article -
11
Ricolinostat (ACY‐1215) induced inhibition of aggresome formation accelerates carfilzomib‐induced multiple myeloma cell death
Published in British journal of haematology (01-05-2015)“…Summary Proteasome inhibition induces the accumulation of aggregated misfolded/ubiquitinated proteins in the aggresome; conversely, histone deacetylase 6…”
Get full text
Journal Article -
12
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells
Published in Blood (22-05-2014)“…The function and survival of normal and malignant plasma cells depends on the elaborately regulated ubiquitin proteasome system. Proteasome inhibitors such as…”
Get full text
Journal Article -
13
Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells
Published in The Journal of experimental medicine (04-07-2011)“…Sustained long-term antibody levels are the cornerstone of protective immunity, yet it remains unclear how they are durably maintained. A predominant theory…”
Get full text
Journal Article -
14
CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma
Published in Blood (12-06-2014)“…Chemotherapeutic resistance remains a significant hurdle in the treatment of multiple myeloma (MM) and is significantly mediated by interactions between MM…”
Get full text
Journal Article -
15
Phosphorylation alters Bim‐mediated Mcl‐1 stabilization and priming
Published in The FEBS journal (01-07-2018)“…Mcl‐1 is a highly labile protein, subject to extensive post‐translational regulation. This distinguishes Mcl‐1 from other antiapoptotic proteins and…”
Get full text
Journal Article -
16
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
Published in The Journal of clinical investigation (01-08-2023)“…Entry of antigen-specific T cells into human tumors is critical for immunotherapy, but the underlying mechanisms are poorly understood. Here, we combined…”
Get full text
Journal Article -
17
Game of Bones: How Myeloma Manipulates Its Microenvironment
Published in Frontiers in oncology (09-02-2021)“…Multiple myeloma is a clonal disease of long-lived plasma cells and is the second most common hematological cancer behind Non-Hodgkin's Lymphoma. Malignant…”
Get full text
Journal Article -
18
Bortezomib-induced “BRCAness” sensitizes multiple myeloma cells to PARP inhibitors
Published in Blood (08-12-2011)“…Chromosomal instability is a defining feature of clonal myeloma plasma cells that results in the perpetual accumulation of genomic aberrations. In addition to…”
Get full text
Journal Article -
19
β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma
Published in Haematologica (Roma) (01-09-2022)Get full text
Journal Article -
20
Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion
Published in Blood (09-06-2011)“…Integrin-β7 (ITGB7) mRNA is detected in multiple myeloma (MM) cells and its presence is correlated with MAF gene activation. Although the involvement of…”
Get full text
Journal Article